DF Dent & Co’s Vanguard Health Care ETF VHT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$328K Hold
1,204
0.01% 236
2025
Q4
$347K Hold
1,204
0.01% 226
2025
Q3
$313K Hold
1,204
﹤0.01% 237
2025
Q2
$299K Hold
1,204
﹤0.01% 222
2025
Q1
$319K Hold
1,204
﹤0.01% 223
2024
Q4
$305K Hold
1,204
﹤0.01% 225
2024
Q3
$340K Hold
1,204
﹤0.01% 220
2024
Q2
$320K Hold
1,204
﹤0.01% 211
2024
Q1
$326K Hold
1,204
﹤0.01% 225
2023
Q4
$302K Hold
1,204
﹤0.01% 221
2023
Q3
$283K Hold
1,204
﹤0.01% 227
2023
Q2
$295K Hold
1,204
﹤0.01% 225
2023
Q1
$287K Hold
1,204
﹤0.01% 216
2022
Q4
$299K Hold
1,204
﹤0.01% 212
2022
Q3
$269K Hold
1,204
﹤0.01% 210
2022
Q2
$284K Hold
1,204
﹤0.01% 203
2022
Q1
$306K Hold
1,204
﹤0.01% 215
2021
Q4
$321K Hold
1,204
﹤0.01% 211
2021
Q3
$298K Hold
1,204
﹤0.01% 203
2021
Q2
$298K Hold
1,204
﹤0.01% 207
2021
Q1
$275K Hold
1,204
﹤0.01% 207
2020
Q4
$269K Hold
1,204
﹤0.01% 203
2020
Q3
$246K Buy
+1,204
New +$244K ﹤0.01% 199

Other funds holding VHT

DF Dent & Co's VHT Position: Q1 2026 in Review

DF Dent & Co held its Vanguard Health Care ETF (VHT) position steady in Q1 2026 at 1,204 shares worth $328K. The position accounts for 0.01% of the portfolio, ranked #236.

DF Dent & Co first reported a position in VHT in Q3 2020 and has held it in 23 quarters since. The position peaked at $347K in Q4 2025. 1,085 funds tracked by Wall St. Rank hold VHT as of Q1 2026.

  • DF Dent & Co held 1,204 shares of Vanguard Health Care ETF worth $328K as of Q1 2026.
  • DF Dent & Co left its Vanguard Health Care ETF share count unchanged in Q1 2026.
  • Vanguard Health Care ETF made up 0.01% of DF Dent & Co's portfolio in Q1 2026, its #236 holding.
  • DF Dent & Co first reported a position in Vanguard Health Care ETF in Q3 2020 and has held it in 23 quarters since.
  • DF Dent & Co's Vanguard Health Care ETF position peaked at $347K in Q4 2025.
  • 1,085 funds tracked by Wall St. Rank held Vanguard Health Care ETF as of Q1 2026.

Based on DF Dent & Co's 13F filing for Q1 2026, filed 15 May 2026.